AGIP Best Practice Statement for HMBT

AGIP encourage the use of these standards within clinical research in order to provide objective evidence of the clinical utility of HMBT.

NICE guidance on SeHCAT (Tauroselcholic [75Selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss